Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image31th March 2025 Vol. No. 14 ; Issue No.676
Publications

1. Sharma G, Jadhav P, Banerjee S, Gupta D, Anand M, Ganguly K, Srivastava S, CM Krishna (2025). Serum Raman Spectroscopy – An exploratory study for detection of chronic obstructive pulmonary disease. Vibrational Spectroscopy.

2. Sawant P, Saoba S, Kadam P, Gupta D, Ponnada AK, Khanna D, Perera S, Tshomo U, Ervik M, Mery L, Bray F, Budukh A (2025). The Nirmiti application: An innovative tool for extending CanReg5 analyses to cancer mortality and paediatric cancer. International Journal of Cancer.

Site of the Week

Pedican is committed to establishing a comprehnsive gene resource for pediatric/childhood cancer. It includes Literature data, Clinical relevant variants, Gene expression profiles, Biological pathways.

desktop Image
Interesting Reads

Zhang X, Zhao H, Wan M, Man J, Zhang T, Yang X, Lu M (2025). Associations of 2923 plasma proteins with incident inflammatory bowel disease in a prospective cohort study and genetic analysis. Nature Communications. 16(1):2813.

Video of the Week
The Evolution of Hepato-Oncology
Upcoming Events
Immunology in Health & Disease- Coupling Ayurveda with Life Sciences

April 29-30, 2025

At ACTREC, Tata Memorial Centre, Kharghar

7th Thyroid Preceptorship Program

April 7 - 12, 2025

At Tata Memorial Hospital, Mumbai

Tobacco Control & Cessation

May 20-21, 2025

At Tata Memorial Hospital, Parel, Mumbai

Do You Know?

In 2016, FDA accelerated approval to palbociclib with fulvestrant(Faslodex) to treat advance breast cancer that worsend following intial hormone therapy.

back Image
Cancer News
Breast cancer breakthrough: Tata Memorial research finds weak spot in aggressive cancer cells and an old drug to treat it

The Indian Express, 25/03/2025

Researchers at Tata Memorial Centre’s Advanced Centre for Treatment, Research and Education in Cancer (TMC-ACTREC) lab wanted to figure out how some cancer cells lie dormant and survive chemotherapy. Nandini Verma, principal investigator, says, “When cancer cells are treated...

Genetically modified natural killer cells show promise in cancer immunotherapy.

MedicalXpress, 24/03/2025

The goal of the study was to confirm whether modified NK cells had the capacity to overcome the negative effects of the TGF-β and Activin A molecules in preclinical models of HER2-positive breast cancer tumor cells and metastatic colorectal cancer cells...

Experimental treatment uses engineered fat cells to “Starve” tumors.

National Cancer Institute, 27/03/2025

In the study, researchers genetically engineered white fat cells the most common type of fat in the body—to aggressively consume nutrients such as glucose and fatty acids. When the engineered fat cells were implanted near tumors in mice, the tumors grew more slowly than tumors in mice without...

2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)